ANIK vs NKE · rev $62.2M vs P/E 35, rev $46.40B
Anika Therapeutics Inc (ANIK) versus Nike Inc (NKE) — a side-by-side from cached financials, not a winner call.
Anika Therapeutics Inc (ANIK) is a drug manufacturers - specialty & generic company listed on US.
Nike Inc (NKE) is a footwear & accessories company listed on US. It is led by Elliott J. Hill.
Latest reported ANIK revenue for 2026-06-30 was $62.2M. Net income was -$1.7M. ANIK currently screens at market cap $161.3M.
Latest reported NKE revenue for 2026-05-31 was $46.40B. Net income was $3.11B. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
ANIK currently screens at market cap $161.3M. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
Not investment advice. Open the ANIK and NKE stock pages for the full models.
Not investment advice.